Australia markets open in 9 hours 20 minutes

Processa Pharmaceuticals, Inc. (PCSA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.4701+0.8501 (+52.32%)
As of 10:39AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 4.63M
Enterprise value 71.05k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.93
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.01

Trading information

Stock price history

Beta (5Y monthly) 0.52
52-week change 3-85.27%
S&P500 52-week change 322.64%
52-week high 318.0000
52-week low 31.4000
50-day moving average 32.1971
200-day moving average 36.0894

Share statistics

Avg vol (3-month) 3433.82k
Avg vol (10-day) 3124.18k
Shares outstanding 52.86M
Implied shares outstanding 62.86M
Float 82.49M
% held by insiders 111.27%
% held by institutions 11.96%
Shares short (15 Apr 2024) 4189.63k
Short ratio (15 Apr 2024) 40.46
Short % of float (15 Apr 2024) 47.13%
Short % of shares outstanding (15 Apr 2024) 46.64%
Shares short (prior month 15 Mar 2024) 440.25k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 323 Dec 2019
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 322 Jan 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-99.41%
Return on equity (ttm)-178.52%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -11.46M
Net income avi to common (ttm)-11.12M
Diluted EPS (ttm)-8.4800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.71M
Total cash per share (mrq)1.65
Total debt (mrq)150.55k
Total debt/equity (mrq)3.02%
Current ratio (mrq)7.71
Book value per share (mrq)3.88

Cash flow statement

Operating cash flow (ttm)-8.06M
Levered free cash flow (ttm)-4.11M